-
Mashup Score: 5ADD YOUR NAME: Sign the Open Letter in Support of NIH Staff - 9 day(s) ago
Join the courageous and committed National Institutes of Health (NIH) public servants by adding your name now.
Source: actionnetwork.orgCategories: General Medicine NewsTweet
-
Mashup Score: 4HHS releases more detailed 2026 budget disclosing scope of cuts - 14 day(s) ago
On Friday, the HHS fleshed out a preliminary budget released in the spring and gave new details about which of its programs would be terminated if the Trump administration gets its way.
Source: www.healthcaredive.comCategories: General Medicine NewsTweet-
Latest plans from our fearless leaders @HHSGov: • $27.5B (44%) cut to @NIH (incl. the 15% indirect cap) • Reducing institutes to 8 (NCI stays, NIDDK does not) • Nearly $4B cut to CDC • $14B allocated for a new "Administration for a Healthy America" 🤦♂️ https://t.co/pAF26RfDHH
-
-
Mashup Score: 3KRON4 talks with UCSF Dr. Matt Cooperberg about Prostate Cancer. - 19 day(s) ago
The Bay Area’s Local News Station
Source: www.kron4.comCategories: General Medicine NewsTweet-
A few thoughts on #prostatecancer screening and the outlook for @joebiden from @kron4news last week. A couple highlights 🧵: https://t.co/XUpq1r0Qti
-
-
Mashup Score: 31KRON4 talks with UCSF Dr. Matt Cooperberg about prostate cancer - 20 day(s) ago
https://www.kron4.com
Source: www.youtube.comCategories: General Medicine NewsTweet-
This took a couple days to post, but here are a few thoughts@kron4newson #prostatecancer screening and the outlook for@JoeBiden. A few summary highlights follow: https://t.co/RcnbyTOO3r @UCSFCancer @UCSFUrology
-
-
Mashup Score: 4
With Biden’s prostate cancer in the news, men may be wondering whether and at what age to be screened. Advice about the value PSA tests has fluctuated. Here’s what to know.
Source: www.npr.orgCategories: General Medicine NewsTweet-
"The pros and cons of PSA tests for prostate cancer for midlife and older men" @NPRHealth @NPR https://t.co/e5ZUsl3rdX
-
-
Mashup Score: 27Surgeons Perform First Human Bladder Transplant - 1 month(s) ago
The procedure could be life-changing for some people with debilitating conditions.
Source: www.nytimes.comCategories: General Medicine NewsTweet-
They finally did a bladder transplant. Would be great to avoid neobladder complications, but is long term immunosuppression better? https://t.co/bSqydoRf9o
-
-
Mashup Score: 6UCSF Department of Urology - 2 month(s) ago
UCSF is known for a spectrum of research in urological cancers, non-cancerous diseases, and pediatric urology. Specialty: Drug Therapies, Treatment Interventions, Nutritional and Lifestyle Interventions, Active Surveillance Performance of clinical research is a departmental priority. The department and affiliated programs are conducting investigational studies of treatments for genitourinary cancer and other conditions with the goal of improving diagnosis, treatment, and follow-up of urologic disease.
Source: urology.ucsf.eduCategories: General Medicine NewsTweet-
New website @UCSFUrology! 🙌 https://t.co/Q0mipmEUl2
-
-
Mashup Score: 1Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial - PubMed - 3 month(s) ago
ClinicalTrials.gov Identifier: NCT02926911.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
The COMET trial out in print this week ICYM the e-pub. Active surveillance must be the only example in the history of oncology in which #prostatecancer is ahead of #breastcancer! It's great news. @JAMA_current https://t.co/SM7WdjXfJa
-
-
Mashup Score: 1Facebook - 4 month(s) ago
🚨 Renaming the Gulf of Mexico to “Gulf of America” Could Cost Taxpayers Over $1 Billion! 🚨 Some politicians want to rename the Gulf of Mexico to the…
Source: www.facebook.comCategories: General Medicine News, Hem/OncsTweet-
Turns out if the #gulfofamerica absurdity actually sticks it could cost us up to $1B. Because, y’know, gov’t efficiency is important and stuff 🤦♂️🇺🇸🤢 https://t.co/xZrEeH8tCz
-
-
Mashup Score: 0
The SAKK 09/10 trial randomized biochemically-recurrent prostate cancer patients to salvage radiation 64Gy vs. 70Gy, and the NRG/RTOG 0126 randomized intermediate-risk prostate cancer patients to definitive radiation 70.2Gy vs. 79.2Gy. We investigated a previously developed Post-Operative Radiation Therapy Outcomes Score (PORTOS) to identify preferential benefit from radiation dose escalation (DE).
Source: www.annalsofoncology.orgCategories: General Medicine News, Oncologists1Tweet-
@Decipher_VCYT BTW here's the manuscript: https://t.co/Toc6bcRaOo
-
Link here to join the #bethesdadeclaration, solidarity for science and with @nih. Please RT! 🙏 https://t.co/AuKrQr4t32